Plans, Designs, and Analyses for Clinical Trials of Anti-Cocaine Medications
- 1 June 1999
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Psychopharmacology
- Vol. 19 (3), 246-256
- https://doi.org/10.1097/00004714-199906000-00008
Abstract
Increased interest in addiction psychopharmacology has raised unique methodologic issues in the design, conduct, and analysis of outcomes in clinical trials of therapeutic agents for drug dependence. This article summarizes issues raised at a meeting in Palo Alto, California, on November 4, 1996, that was sponsored by the Medication Development Division of the National Institute on Drug Abuse and the Department of Veterans Affairs Cooperative Studies Program to discuss the methodologic issues in clinical trials of cocaine pharmacotherapy.This publication has 29 references indexed in Scilit:
- Assessment of cocaine use with quantitative urinalysis and estimation of new usesAddiction, 1997
- Identification of Causal Effects Using Instrumental VariablesJournal of the American Statistical Association, 1996
- Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.Experimental and Clinical Psychopharmacology, 1996
- Treating adult marijuana dependence: A test of the relapse prevention model.Journal of Consulting and Clinical Psychology, 1994
- Adherence to treatment and health outcomesArchives of Internal Medicine, 1993
- The effects of psychosocial services in substance abuse treatmentJAMA, 1993
- Naltrexone in the Treatment of Alcohol DependenceArchives of General Psychiatry, 1992
- Psychotherapy for Opiate AddictsArchives of General Psychiatry, 1983
- Bayesian Inference for Causal Effects: The Role of RandomizationThe Annals of Statistics, 1978
- A Behavioral Paradigm for the Evaluation ofArchives of General Psychiatry, 1976